BVS BIOVENTUS INC revenue, earnings and financials
For the quarter ended June 27, 2026, BIOVENTUS INC reported revenue of $153M (up 3.8% from a year earlier), net income of $33.4M and diluted EPS of $0.47; over the last four quarters revenue was $582M and net income $54.5M; for the fiscal year ended December 2025 revenue was $568M, down 0.9% on the year before.
BVS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $568M, gross profit $388M, operating income $54.0M, net income $22.7M (margin 4.0%), EPS $0.33
- Fiscal year ended Dec 2024: revenue $573M, gross profit $388M, operating income −$15.2M, net income −$36.1M (margin -6.3%), EPS −$0.56
- Fiscal year ended Dec 2023: revenue $512M, gross profit $328M, operating income −$81.7M, net income −$156M (margin -30.5%), EPS −$2.49
- Fiscal year ended Dec 2022: revenue $512M, gross profit $331M, operating income −$167M, net income −$159M (margin -31.0%), EPS −$2.59
- Fiscal year ended Dec 2021: revenue $431M, gross profit $303M, operating income $12.1M, net income $19.4M (margin 4.5%), EPS −$0.15
BVS quarterly revenue and earnings
- Quarter ended Jun 27, 2026: revenue $153M (up 3.8% year over year), net income $33.4M, EPS $0.47
- Quarter ended Mar 28, 2026: revenue $132M (up 6.6% year over year), net income $3.11M, EPS $0.04
- Quarter ended Dec 31, 2025 (from the annual report): revenue $158M (up 2.8% year over year), net income $14.8M, EPS $0.21
- Quarter ended Sep 27, 2025: revenue $139M (down 0.2% year over year), net income $3.16M, EPS $0.05
- Quarter ended Jun 28, 2025: revenue $148M (down 2.4% year over year), net income $7.46M, EPS $0.11
- Quarter ended Mar 29, 2025: revenue $124M (down 4.3% year over year), net income −$2.64M, EPS −$0.04
- Quarter ended Dec 31, 2024 (from the annual report): revenue $154M (up 13.5% year over year), net income −$388K, EPS $0.00
- Quarter ended Sep 28, 2024: revenue $139M (up 15.0% year over year), net income −$5.17M, EPS −$0.08
- Quarter ended Jun 29, 2024: revenue $151M (up 10.3% year over year), net income −$25.7M, EPS −$0.40
- Quarter ended Mar 30, 2024: revenue $129M (up 8.7% year over year), net income −$4.89M, EPS −$0.08
- Quarter ended Dec 31, 2023 (from the annual report): revenue $135M (up 7.6% year over year), net income −$6.10M, EPS −$0.07
- Quarter ended Sep 30, 2023: revenue $121M (down 6.1% year over year), net income −$7.30M, EPS −$0.12
- Quarter ended Jul 1, 2023: revenue $137M (down 2.3% year over year), net income −$3.68M, EPS −$0.06
- Quarter ended Apr 1, 2023: revenue $119M (up 1.5% year over year), net income −$139M, EPS −$2.24
- Quarter ended Dec 31, 2022 (from the annual report): revenue $126M (down 3.5% year over year), net income −$31.9M, EPS −$0.53
- Quarter ended Oct 1, 2022: revenue $129M (up 18.2% year over year), net income −$108M, EPS −$1.76
- Quarter ended Jul 2, 2022: revenue $140M (up 27.8% year over year), net income −$7.25M, EPS −$0.11
- Quarter ended Apr 2, 2022: revenue $117M (up 43.4% year over year), net income −$11.3M, EPS −$0.19
- Quarter ended Dec 31, 2021 (from the annual report): revenue $130M, net income −$364K, EPS $0.00
- Quarter ended Oct 2, 2021: revenue $109M, net income −$1.07M, EPS −$0.03
BVS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $74.7M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $38.8M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow $15.3M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$13.5M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow $23.0M, share buybacks n/a
BVS balance sheet
- Jun 27, 2026: cash $29.5M, total assets $673M, total liabilities $396M, shareholders' equity $228M, long-term debt $230M
- Mar 28, 2026: cash $35.8M, total assets $651M, total liabilities $416M, shareholders' equity $189M, long-term debt $253M
- Dec 31, 2025: cash $51.2M, total assets $684M, total liabilities $455M, shareholders' equity $184M, long-term debt $279M
- Sep 27, 2025: cash $42.2M, total assets $702M, total liabilities $494M, shareholders' equity $166M, long-term debt $311M
- Jun 28, 2025: cash $32.9M, total assets $707M, total liabilities $505M, shareholders' equity $161M, long-term debt $298M
- Mar 29, 2025: cash $22.8M, total assets $691M, total liabilities $506M, shareholders' equity $148M, long-term debt $309M
- Dec 31, 2024: cash $41.6M, total assets $728M, total liabilities $542M, shareholders' equity $148M, long-term debt $308M
- Sep 28, 2024: cash $43.1M, total assets $769M, total liabilities $583M, shareholders' equity $149M, long-term debt $345M
What is BVS's revenue?
BIOVENTUS INC reported $582M of revenue over its last four quarters, through June 27, 2026.
Is BVS profitable?
Yes. BIOVENTUS INC earned $54.5M over the last four quarters.
What is BVS's EPS?
Diluted earnings per share over the last four quarters were $0.77; $0.47 in the latest quarter.